Cargando…
A Polar Sulfamide Spacer Significantly Enhances the Manufacturability, Stability, and Therapeutic Index of Antibody–Drug Conjugates
Despite tremendous efforts in the field of targeted cancer therapy with antibody–drug conjugates (ADCs), attrition rates have been high. Historically, the priority in ADC development has been the selection of target, antibody, and toxin, with little focus on the nature of the linker. We show here th...
Autores principales: | Verkade, Jorge M. M., Wijdeven, Marloes A., van Geel, Remon, Janssen, Brian M. G., van Berkel, Sander S., van Delft, Floris L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698870/ https://www.ncbi.nlm.nih.gov/pubmed/31544864 http://dx.doi.org/10.3390/antib7010012 |
Ejemplares similares
-
Correction: Verkade, J.M.M.; et al. A Polar Sulfamide Spacer Significantly Enhances the Manufacturability, Stability, and Therapeutic Index of Antibody–Drug Conjugates. Antibodies 2018, 7, 12
por: Verkade, Jorge M. M., et al.
Publicado: (2018) -
Enzymatic glycan remodeling–metal free click (GlycoConnect™) provides homogenous antibody-drug conjugates with improved stability and therapeutic index without sequence engineering
por: Wijdeven, Marloes A., et al.
Publicado: (2022) -
Non-Genetic Generation of Antibody Conjugates Based
on Chemoenzymatic Tyrosine Click Chemistry
por: Bruins, Jorick J., et al.
Publicado: (2021) -
Benzylsulfamide
por: Gelbrich, Thomas, et al.
Publicado: (2011) -
Synthesis of New Fused Benzothiadiazepines and Macrocyclic Sulfamides Starting from N,N-Disubstituted Sulfamides and N(Boc)-Sulfamides
por: Dehamchia, Mohamed, et al.
Publicado: (2012)